Human embryo editing against disease is unsafe and unproven — despite rosy predictions

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

Mathematical modelling suggests that it is theoretically possible to reduce risk of common diseases using heritable genome editing. Scientists argue that the technology involves considerable risk and uncertain benefits.

Original languageEnglish
Pages (from-to)554-556
Number of pages3
JournalNature
Volume637
Issue number8046
DOIs
StatePublished - 16 Jan 2025

Bibliographical note

Publisher Copyright:
© Springer Nature Limited 2025.

Keywords

  • CRISPR-Cas9 genome editing
  • Ethics

Fingerprint

Dive into the research topics of 'Human embryo editing against disease is unsafe and unproven — despite rosy predictions'. Together they form a unique fingerprint.

Cite this